期刊文献+

妊娠水平孕酮体外对HIV-1感染和复制的影响

Effects of progesterone corresponding to pregnant level on HIV-1 infecting and replicating in vitro
下载PDF
导出
摘要 目的:研究相当于妊娠后外周血和胎盘局部浓度的孕酮(P4)体外对HIV-1感染及复制的影响。方法:检测终浓度为10-6mol/L(相当于妊娠妇女外周血水平)和10-5mol/L(相当于母胎界面局部浓度)的P4对HIV-1介导细胞融合的影响;ELISA法检测感染HIV的MT-2细胞培养上清p24抗原含量来探讨对HIV-1复制的影响;流式细胞术检测对淋巴细胞活化后CD69表达的影响和3H-TdR掺入法检测对淋巴细胞增殖的影响。结果:10-5mol/L的P4可以明显抑制HIV-1介导的细胞融合,并且降低感染细胞培养上清中p24抗原含量,两种浓度对淋巴细胞的活化和增殖都有抑制作用。结论:相当于妊娠后母胎界面局部浓度的P4体外可以抑制HIV-1感染和复制,其机制与抑制淋巴细胞活化和增殖有关。 Objective :To investigate the effects of progesterone( P4 ), corresponding to peripheral blood levels during pregnancy and the fetal-maternal interface, on HIV-1 infection and replication in vitro. Methods:P4 in final concentration of 10^-6 mol/L, corresponding peripheral blood levels during pregnancy, and 10^-5 mol/L detected at the fetal-maternal interface on HIV-1 infection and rephcation in vitro, which were detected by HIV-1 mediated cell fusion and p24 production monitored by ELISA respectively. The effects of P4 on activation and proliferation of lymphocytes were determined by detecting CD69 expression by multicolor flow cytometric analysis and the 3H-thymidine( [^3H]-TdR) incorporation. Results:P4 could dramatically inhibit formation of fusions mediated by HIV- 1 and decrease releasing of p24 in concentration of 10^-5 mol/L, and P4 could inhibit activation and proliferation of lymphocytes in given concentration. Conclusion:P4 in concentration of 10^-5 mol/L detected at the fetal-maternal interface can inhibit the infection and rephcation of HIV-1 in vitro, and the mechanism correlate to inhibiting effect on activation and proliferation of lymphocytes.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2006年第5期445-448,共4页 Chinese Journal of Immunology
基金 国家自然科学基金面上项目(30500466) 广东省自然科学基金博士启动项目(5300419)
关键词 妊娠 孕酮 人类免疫缺陷病毒 细胞融合 活化 Pregnancy Progesterone HIV-1 Fusion Activation
  • 相关文献

参考文献1

二级参考文献18

  • 1Collins RA, Ng TB. Fong WE Wan CC. Yeung HW. A comparison of human immunodeficiency virus type 1 inhibition by partially purified aqueous extracts of Chinese medicinal herbs. Life Sci 1997: 60: 345-51.
  • 2Liu S. Jiang S, Wu Z. Lti L. Zhang J, Zhu Z. Wu S. Identification of inhibitors of the HIV-I gp41 six-helix bundle formation from extracts of Chinese medicinal herbs Prunella vulgaris and Rhizoma cibotte. Life Sci 2002: 71: 1779-91.
  • 3Tan GT, Pezzuto JM, Kinghom AD, Hughes SH. Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV- 1 ) reverse transcriptase. J Nat Prod 1991 :54: 143-54.
  • 4Xu HX, Wan M, Dong H, But PP, Foo LY. Inhibitory activity of flavonoids and tannins against HIV-1 protease. Biol Pharm Bull 2000: 23: 1072-6.
  • 5Au TK. Lain TL, Ng TB, Fong WE Wan DC. A comparison of HIV-1 integrase inhibition by aqueous and methanol extracts of Chinese medicinal herbs. Life Sci 2001: 68: 1687-94.
  • 6Chan DC, Kim PS. HIV entry and its inhibition. Cell 1998:93: 681-4.
  • 7Jiang S. Debanth AK. The HIV-1 gp41 core: a target for developing HIV-1 inhibitors. Curr Top Biochem Res 2000:2: 1-17.
  • 8Chan DC, Fass D, Berger JM, Kim PS. Core structure of gp41 from the HIV envelope glycoprotein. Cell 1997: 89:263-73.
  • 9Weissenhorn W. Dessen A, Harrison SC, Skehel JJ, Wiley DC. Atomic structure of the ectodomain from HIV-1 gp41.Nature 1997: 387: 426-8.
  • 10Jiang S, Lin K, Strick N, Neurath AR. HIV-I inhibition by a peptide. Nature 1993: 365: 113.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部